ipscell.com
Bad news as Geron to quit hESC SCI trial for financial reasons - The Niche
Reportedly, Geron has decided to only focus on cancer research and for financial reasons has shut down its hESC trial for spinal cord injury.
Professor Paul Knoepfler, Ph.D.
